ADRAMEL Trademark

Trademark Overview

On Wednesday, December 14, 2016, a trademark application was filed for ADRAMEL with the United States Patent and Trademark Office. The USPTO has given the ADRAMEL trademark a serial number of 87268354. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 3, 2020. This trademark is owned by Teva Pharmaceuticals USA, Inc.. The ADRAMEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain; contraceptives
adramel

General Information

Serial Number87268354
Word MarkADRAMEL
Filing DateWednesday, December 14, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 3, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 2, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological diseases, respiratory diseases, cancer and pain; contraceptives

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 20, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceuticals USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454
Party NameTeva Pharmaceuticals USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNorth Wales, PA 19454

Trademark Events

Event DateEvent Description
Monday, August 3, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 3, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 31, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 30, 2019EXTENSION 5 GRANTED
Wednesday, December 18, 2019EXTENSION 5 FILED
Monday, December 30, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 18, 2019TEAS EXTENSION RECEIVED
Tuesday, June 25, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2019EXTENSION 4 GRANTED
Tuesday, June 25, 2019EXTENSION 4 FILED
Tuesday, June 25, 2019TEAS EXTENSION RECEIVED
Friday, December 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 19, 2018EXTENSION 3 GRANTED
Wednesday, December 19, 2018EXTENSION 3 FILED
Wednesday, December 19, 2018TEAS EXTENSION RECEIVED
Saturday, June 23, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 21, 2018EXTENSION 2 GRANTED
Thursday, June 21, 2018EXTENSION 2 FILED
Thursday, June 21, 2018TEAS EXTENSION RECEIVED
Thursday, June 21, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 22, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 20, 2017EXTENSION 1 GRANTED
Wednesday, December 20, 2017EXTENSION 1 FILED
Wednesday, December 20, 2017TEAS EXTENSION RECEIVED
Tuesday, June 27, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 2, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2017PUBLISHED FOR OPPOSITION
Wednesday, April 12, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 16, 2017ASSIGNED TO EXAMINER
Tuesday, December 20, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, December 17, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

adramel diseases cancer pain contraceptives respiratory pharmaceutical treatment neurological preparations